Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Short term Debt (2016 - 2025)

Palisade Bio has reported Short term Debt over the past 11 years, most recently at $235000.0 for Q3 2025.

  • Quarterly Short term Debt changed N/A to $235000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $235000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $143000.0 for FY2023, N/A changed from the prior year.
  • Short term Debt was $235000.0 for Q3 2025 at Palisade Bio, up from $66000.0 in the prior quarter.
  • Over five years, Short term Debt peaked at $1.1 million in Q2 2021 and troughed at $66000.0 in Q2 2025.
  • The 4-year median for Short term Debt is $143000.0 (2023), against an average of $254125.0.
  • Year-over-year, Short term Debt plummeted 91.69% in 2021 and then plummeted 51.75% in 2025.
  • A 4-year view of Short term Debt shows it stood at $87000.0 in 2021, then soared by 64.37% to $143000.0 in 2023, then rose by 4.2% to $149000.0 in 2024, then skyrocketed by 57.72% to $235000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Short term Debt are $235000.0 (Q3 2025), $66000.0 (Q2 2025), and $69000.0 (Q1 2025).